PTSD treatment in Eatontown, New Jersey

Posttraumatic stress disorder (PTSD) develops in some people after exposure to a traumatic event. The diagnostic criteria are specific. The DSM-5-TR — the current diagnostic manual — defines PTSD as the persistent presence of symptoms across four clusters, lasting more than one month, after a qualifying traumatic event.

The four symptom clusters are: intrusion (unwanted memories, flashbacks, nightmares), avoidance (of reminders), negative changes in cognition and mood (persistent negative beliefs, emotional numbing, detachment), and changes in arousal and reactivity (hypervigilance, startle, irritability, sleep problems). A clinical PTSD diagnosis requires symptoms from all four clusters, not just the most-publicized intrusion symptoms.

About 6% of U.S. adults experience PTSD in their lifetime, per NIMH data. Roughly 1 in 11 will be diagnosed at some point. Many more experience trauma without developing PTSD; the majority of trauma survivors recover without clinical intervention. The minority who don't are who PTSD treatment exists for.

We don't diagnose in copy on a website. The criteria below exist so you can match what you're experiencing to a recognizable pattern. The diagnosis itself is made through a clinical interview, usually 60 to 90 minutes long, with a clinician trained in trauma evaluation.

What separates PTSD from a difficult emotional response after a hard event: duration (more than one month), pervasiveness (symptoms across all four clusters), and impairment (something you used to handle, you can't right now).

Trauma takes many forms. The treatment framework is shared; the practical entry points differ.

Acute trauma — single event. Serious accidents, assaults, natural disasters, medical events, witnessing harm to someone else. Symptoms can begin within days or take months to surface. Treatment for single-event trauma is often more time-limited than for sustained trauma — many patients respond to 8 to 12 sessions of focused work.

Sexual assault and intimate partner violence. PTSD prevalence is meaningfully higher in survivors of sexual assault than in trauma broadly. Treatment requires a clinician who specifically does this work — pacing matters, trust matters, and the clinician's preparation matters. Several of our clinicians do this work; tell our intake team this is the focus and we'll match you appropriately.

Combat-related PTSD. Veterans and active-duty service members face a distinct set of considerations: shared experiences that civilian clinicians may not fully understand, comorbidity rates that are different from civilian PTSD, and connection to VA healthcare. We accept Tricare for active military, dependents, and qualifying veterans. For veterans connected to VA care, we coordinate with VA providers when patients want.

Sustained childhood trauma. Repeated trauma during developmental years — chronic abuse, severe neglect, exposure to domestic violence — produces a clinical picture that often differs from single-event PTSD. The ICD-11 (a parallel international diagnostic manual) describes "complex PTSD" or "C-PTSD" as a separate diagnosis with additional symptom clusters around emotion regulation, self-concept, and relationships. The DSM-5-TR doesn't have a separate C-PTSD diagnosis; many patients fitting that pattern are diagnosed with PTSD plus another condition. The treatment framework for sustained childhood trauma is similar to other PTSD treatment but typically takes longer and includes more emphasis on stabilization before reprocessing.

Medical trauma. Cancer treatment, ICU stays, near-death experiences, traumatic births. Often under-recognized as trauma both by patients and by other clinicians. PTSD can develop the same way after medical trauma as after any other form. See our postpartum depression page for the postpartum-PTSD overlap specifically.

Vicarious trauma. Repeated exposure to others' trauma — first responders, healthcare workers, journalists, social workers, attorneys. The DSM-5-TR criteria explicitly include this pathway, and we treat it the same way as direct trauma exposure.

Most people who eventually seek PTSD treatment lived with symptoms for years before they called. The reasons vary. Some weren't sure their experience "counted" as trauma. Some feared that talking about it would make it worse. Some tried to wait it out and found that waiting alone didn't work. None of those reasons mean it's too late.

The threshold for seeking care isn't "I meet every DSM criterion." It's simpler. Has it been more than a month since the event? Are intrusive memories, avoidance, hypervigilance, or emotional numbing affecting how you function? If yes, talk to someone. A clinician sorts out whether what you're experiencing fits PTSD or another related condition, and what the right treatment is.

If you're in active crisis or having thoughts of suicide, call or text 988. The Suicide and Crisis Lifeline is free and available 24/7. PTSD has high comorbidity with depression and suicidal ideation; the crisis line is appropriate. Veterans can press 1 after calling 988 to reach the Veterans Crisis Line. If you're in immediate physical danger, call 911 or go to your nearest emergency room.

The list below collects symptoms patients commonly bring to a first PTSD-focused visit. It's not a diagnostic tool. If several resonate, that's information worth bringing to a clinician.

PTSD has three first-line evidence-based therapies, all with strong research support. They differ in mechanism but produce comparable outcomes for most patients. The right choice depends on what you're working with, your preferences, and your clinician's training.

Eye Movement Desensitization and Reprocessing (EMDR). The most-recognized PTSD treatment in the public conversation, and one of the three first-line approaches per the World Health Organization, the American Psychological Association, and the Department of Veterans Affairs. EMDR uses bilateral stimulation — typically guided eye movements — while you briefly recall a traumatic memory. The mechanism is debated; the outcome is consistent. Many patients find that the memory loses its emotional charge after several sessions. A typical course runs 8 to 12 sessions of 60 to 90 minutes. The early sessions focus on history-taking and stabilization before any reprocessing begins. Lisa Patel on our team is EMDRIA-certified with additional perinatal training.

Cognitive Processing Therapy (CPT). A structured cognitive therapy specifically developed for PTSD. CPT focuses on the thoughts and beliefs the trauma has shaped — about safety, trust, power, esteem, and intimacy — and works to update those beliefs. A typical course runs 12 sessions. CPT is the protocol the Department of Veterans Affairs uses most heavily; the evidence base in veteran populations is unusually strong. Some patients prefer CPT to EMDR because it relies on words rather than memory recall.

Prolonged Exposure (PE). Structured therapy that asks patients to revisit the traumatic memory repeatedly in session, in a contained way, until the memory loses its acute charge. PE also includes in vivo exposure — gradually approaching avoided situations in life. A typical course runs 8 to 15 sessions. PE is uncomfortable in the short term and effective in the long term. It's particularly well-evidenced for combat-related PTSD.

Trauma-focused CBT. A broader umbrella that overlaps with both CPT and PE. We use trauma-focused CBT for patients whose presentation calls for a more flexible structure than the manualized protocols above. Many of our clinicians blend trauma-focused CBT with EMDR depending on what the session calls for.

What to expect in early sessions. Trauma treatment doesn't start with the trauma. The first 2 to 4 sessions are usually about history-taking, stabilization skills (grounding, distress tolerance), and building enough trust to do the harder work later. A clinician who pushes you to recount the trauma in detail in the first session is doing it wrong.

For the broader services and how they fit, see our therapy page and psychiatry page.

Medication is part of treatment for many PTSD patients. It doesn't replace trauma-focused therapy. It can make trauma-focused therapy possible, especially when sleep is so disrupted that processing-work is impossible without it.

SSRIs are the first-line medication. Sertraline (Zoloft) and paroxetine (Paxil) are FDA-approved specifically for PTSD. Fluoxetine and other SSRIs are commonly used off-label with similar effect. Response timelines run 4 to 8 weeks at adequate dose, similar to depression. SSRIs reduce the intensity of all four PTSD symptom clusters in many patients.

SNRIs are second-line. Venlafaxine has good evidence for PTSD and is often used when SSRIs haven't worked or have caused intolerable side effects.

Prazosin for nightmares. Prazosin is an alpha-1 blocker (originally a blood-pressure medication) that significantly reduces trauma-related nightmares in many patients. Sleep quality often improves within days. The evidence base is strongest in veteran populations but applies broadly. We often use prazosin alongside an SSRI.

Mirtazapine for sleep. Used in some patients when sleep disruption is severe and SSRIs aren't enough. Mirtazapine is sedating and improves sleep quickly, with the trade-off of weight gain in some patients.

What doesn't work — and what can make PTSD worse. Benzodiazepines (Xanax, Ativan, Klonopin) are not effective for PTSD and can make it worse over time. Multiple studies have found that long-term benzodiazepine use is associated with worse PTSD outcomes. Short-term use during acute crises may be reasonable; long-term daily use as a primary PTSD treatment is contraindicated by current evidence. We do not initiate benzodiazepine treatment for PTSD. If you came to us already taking one, we'll talk through the taper carefully.

Antipsychotics. Sometimes used as augmentation in treatment-resistant PTSD with prominent psychotic features. Not first-line, used cautiously.

The honest framing. Medication reduces symptoms; it does not process trauma. Most patients who get the most from PTSD treatment combine medication for sleep and baseline anxiety with one of the three first-line therapies. The combination outperforms either alone.

For ongoing prescribing, see our medication management page.

Comorbidity is the rule for PTSD, not the exception. Most patients with PTSD also meet criteria for at least one other condition. The most common patterns:

PTSD + depression. Roughly half of people with PTSD also have major depressive disorder. The conditions interact — depression worsens the avoidance and emotional-numbing symptoms of PTSD; PTSD's hypervigilance and sleep disruption worsen depression. Treatment usually addresses both, often through the same SSRI plus trauma-focused therapy. See our depression page for the broader framework.

PTSD + substance use. People with PTSD use substances at higher rates than the general population, often as a way to manage hypervigilance, intrusive memories, or sleep disruption. Treatment that addresses only one side tends to relapse the other. We treat co-occurring substance use alongside trauma-focused care; Joseph Vacchiano on our team is dual-licensed as a clinical alcohol and drug counselor (LCADC) and works with patients in this combination regularly.

PTSD + chronic anxiety. Common, especially with sustained or developmental trauma. The treatments overlap with anxiety treatment but are anchored in trauma-focused therapy.

Sleep disruption. Almost universal in PTSD. We treat the sleep symptom directly (often with prazosin for trauma-related nightmares plus sleep hygiene work) alongside the trauma-focused therapy. Sleep often improves first, before the broader PTSD symptoms reduce.

Dissociation. Some PTSD patients experience dissociative symptoms — feeling disconnected from their body or surroundings, time loss, or persistent depersonalization. Dissociative PTSD is a recognized subtype in DSM-5-TR and treatment is adapted accordingly, with more emphasis on stabilization skills before any trauma reprocessing.

The point: most PTSD treatment plans address more than just PTSD. We coordinate care across these threads instead of asking you to manage them in separate offices.

PTSD in adolescents and pre-teens often presents differently from adult PTSD. Symptoms can include behavior changes, drops in school performance, increased irritability, somatic complaints (headaches, stomach pain), and regression to younger behaviors. Younger children may show repetitive trauma-themed play. Older adolescents may look more like adults but with greater behavioral acting-out.

Treatment for adolescent PTSD draws on the same evidence base as adult PTSD, with adaptations. Trauma-focused CBT (TF-CBT) is the most-evidenced approach for children and adolescents, with strong outcomes across many trauma types. EMDR is also used in adolescents. Medication is added when clinically warranted; SSRI evidence in adolescents specifically for PTSD is smaller than for adult PTSD but treatment patterns are similar.

We coordinate with parents at every visit when working with younger adolescents. The exact balance depends on the patient's age, the trauma context, and what the teen consents to share. Where the trauma happened in the family system, the coordination work gets careful.

For full detail on teen-specific care patterns, see teen anxiety and teen depression. PTSD in teens often co-occurs with both.

Honest answer: it depends on what kind of trauma, how long ago, what comorbidity exists, and what treatment path you choose. Some markers:

Single-event PTSD with EMDR or PE. Many patients see substantial symptom reduction in 8 to 12 sessions. Some single-event trauma responds in fewer sessions; some takes longer.

Single-event PTSD with CPT. A typical full course is 12 sessions, structured weekly.

Sustained or developmental trauma (C-PTSD presentation). Treatment usually takes longer — often a year or more of regular work, with stabilization and skill-building before any trauma processing. The pacing is driven by the patient, not the protocol.

Combined therapy plus medication. Medication takes 4 to 8 weeks to reach full effect. Therapy progress runs in parallel. Most patients continue medication for 6 to 12 months after symptoms are well-controlled, then taper.

Maintenance. PTSD symptoms can resurface under stress or trigger exposure. We build relapse-prevention skills into the final phase of treatment so you have tools when life pressure rises. Many patients do periodic booster sessions in the years after intensive treatment.

We don't promise that the trauma stops mattering. We do measure progress with standardized tools (PCL-5, the standard PTSD checklist) at regular intervals so you and your clinician can see what's working. For most patients, what shifts is not the memory of the event but the way the memory currently lives in the body — what activates, what avoidance still costs, what the trauma still tells you about yourself. The goal is a present that's no longer organized around the event.